10mon MSN
Q4 2024 Management View CEO Dan Chard highlighted that 2024 was a transformative year for Medifast due to the increasing adoption of GLP-1 weight loss medications. The company is adapting to these ...
Beyond weight loss: protecting muscle with GLP-1s. Dr Almandoz shares strategies to preserve muscle, optimize body composition, and enhance health outcomes during GLP-1 therapy.
ORLANDO, FLA. — Increasing levels of protein and fiber, stressing portion control and adding savory flavors are ways that ...
Research shows bimagrumab may prevent muscle and bone loss associated with weight loss medications like Wegovy, offering hope ...
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...
Consumer Reports warns that there are important considerations, especially for older adults, before starting these treatments ...
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...
Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.
When celebrities reveal their experiences with newer weight-loss drugs, there are upsides and downsides for patients and ...
Direct-to-consumer telehealth company advertisement that aired during the Super Bowl failed to mention side effects of the drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results